Who founded Neurodon?

Neurodon was founded by Russell Dahl, Brunde Broady in 2019.

Who are Neurodon's investors?

Neurodon's investors include Elevate Ventures.

How much funding has Neurodon raised?

Neurodon has disclosed $500K raised across 1 round.

Where is Neurodon headquartered?

Neurodon is headquartered in Crown Point, US.

Neurodon

Crown Point, US · Founded 2019 · Delaware corporation · 1 known investors

Find your way into Neurodon

115 people in our graph share verified history with the Neurodon team — schools, employers, funds. One of them is your warm intro.

Anthony Philippakisunlockedknows Brunde Broady · together at Yale University (overlapped)

×11knows the team · via Yale University

Neurodon develops small-molecule therapeutics that target cellular calcium imbalance and the endoplasmic reticulum stress pathway, using compounds that allosterically modulate the SERCA enzyme to restore calcium transport. Its disease-modifying approach aims at conditions linked to cellular stress such as diabetes, Alzheimer's, Parkinson's, and Duchenne muscular dystrophy.

Biotech Healthtech

Founders & leadership

Neurodon was founded in 2019 by Russell Dahl and Brunde Broady.

Russell DahlCo-founder

Brunde Broady inFounderBrunde Broady is co-founder and head of business development at Neurodon, a company developing therapeutics for cardiometabolic and neurodegenerative diseases. He holds patents and has authored published work on Calcium ATPase, and serves as a partner at a family venture firm overseeing investments across nutraceutical, tech, and biopharma sectors.

Investors · 1

Elevate VenturesIndianapolis · $20K – $2M

Reported raises · per SEC filings

Form D private placements

$500K disclosed across 1 round · 2019

▶$500KraisedNov 2019 · 1 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Russell DahlExecutive Officer, Director

Offering amount: $500K
Amount sold: $500K
First sale: Oct 2019
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

SoundCloud5 shared keywordsAudio distribution and music-sharing platform for artists and creators.

Bandcamp3 shared keywordsBandcamp is a music platform that enables fans to create and share playlists of music they own from artists they support, with built-in artist compensation and discovery features. The service emphasizes direct artist support by requiring playlist creators to own tracks and limiting free sampling to encourage purchases.

1Mg3 shared keywordsThis is a product listing page on an online pharmacy for Tugain Twins 5 Solution, a topical minoxidil-based medicine sold to treat hair loss and promote hair regrowth. The page provides usage instructions, benefits, side effects, and purchase/return details rather than describing a company.

Companies competing with Neurodon for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 4 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2023	$529.1K
National Institutes of Health (NIH)National Institutes of Health	Phase ISTTR	2023	$286.3K
National Institutes of Health (NIH)National Institutes of Health	Phase IISTTR	2020	$2M
National Institutes of Health (NIH)National Institutes of Health	Phase ISTTR	2018	$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Neurodon do?: Neurodon develops small-molecule therapeutics that target cellular calcium imbalance and the endoplasmic reticulum stress pathway, using compounds that allosterically modulate the SERCA enzyme to restore calcium transport. Its disease-modifying approach aims at conditions linked to cellular stress such as diabetes, Alzheimer's, Parkinson's, and Duchenne muscular dystrophy.
Who founded Neurodon?: Neurodon was founded by Russell Dahl, Brunde Broady in 2019.
Who are Neurodon's investors?: Neurodon's investors include Elevate Ventures.
How much funding has Neurodon raised?: Neurodon has disclosed $500K raised across 1 round.
Where is Neurodon headquartered?: Neurodon is headquartered in Crown Point, US.